about
Medical management of uveitis - current trendsAqueous Humor Levels of Different Interleukins 1-β, 2, 6 and 10, Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in Uveitis Treated with Adalimumab.Recent perspectives on the delivery of biologics to back of the eye.JOVR is Promoting Closer Academic and Scientific Ties between Europe and Iran.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biologic agents in inflammatory eye disease.
@en
Biologic agents in inflammatory eye disease.
@nl
type
label
Biologic agents in inflammatory eye disease.
@en
Biologic agents in inflammatory eye disease.
@nl
prefLabel
Biologic agents in inflammatory eye disease.
@en
Biologic agents in inflammatory eye disease.
@nl
P2860
P1476
Biologic agents in inflammatory eye disease
@en
P2093
Chiara Posarelli
Ilir Arapi
P2860
P304
P577
2011-10-01T00:00:00Z